Clinical Trial

Palmitoylethanolamide in Ulcerative Colitis

Name: Palmitoylethanolamide in Ulcerative Colitis — clinical trial record (NCT07609810)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Evaluate the effects of PEA supplementation on disease activity, health-related quality of life (HRQoL) and inflammatory biomarkers in patients with active mild-to-moderate UC.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2026-05-20; most recent amendment 2026-07-13.

Trial Details

NCT Number	NCT07609810
Lead Sponsor	Ain Shams University
Conditions	Ulcerative Colitis (UC)
Enrollment	60 participants
Start Date	2026-08-15
Primary Completion	2028-12-15 (estimated)
Study Completion	2029-02-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-14